C Cleeland
Overview
Explore the profile of C Cleeland including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
466
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fogelman D, Morris J, Xiao L, Hassan M, Vadhan S, Overman M, et al.
Support Care Cancer
. 2017 Jan;
25(6):1809-1817.
PMID: 28111717
Background: Cachexia is a frequent manifestation of pancreatic cancer, can limit a patient's ability to take chemotherapy, and is associated with shortened survival. We developed a model to predict the...
2.
Shah J, Feng L, Thomas S, Berkova Z, Weber D, Wang M, et al.
Blood Cancer J
. 2016 Feb;
6:e396.
PMID: 26871714
The safety and efficacy of siltuximab (CNTO 328) was tested in combination with lenalidomide, bortezomib and dexamethasone (RVD) in patients with newly-diagnosed, previously untreated symptomatic multiple myeloma. Fourteen patients were...
3.
Sternberg C, Molina A, North S, Mainwaring P, Fizazi K, Hao Y, et al.
Ann Oncol
. 2012 Nov;
24(4):1017-25.
PMID: 23152362
Background: Fatigue is a common, debilitating side-effect of prostate cancer and its treatment. Patient-reported fatigue was evaluated as part of COU-AA-301, a randomized, placebo-controlled, phase III trial of abiraterone acetate...
4.
Armstrong T, Mendoza T, Gning I, Gring I, Coco C, Cohen M, et al.
J Neurooncol
. 2006 Apr;
80(1):27-35.
PMID: 16598415
Background: Symptom occurrence has been shown to predict treatment course and survival in patients with solid tumors. Primary brain tumor (PBT) patients are unique in the occurrence of neurologic symptoms....
5.
Mock V, Atkinson A, Barsevick A, Cella D, Cimprich B, Cleeland C, et al.
Oncology (Williston Park)
. 2001 Feb;
14(11A):151-61.
PMID: 11195408
These guidelines propose a treatment algorithm in which patients are evaluated regularly for fatigue, using a brief screening instrument, and are treated as indicated by their fatigue level. The algorithm's...
6.
Benedetti C, Brock C, Cleeland C, Coyle N, Dube J, Ferrell B, et al.
Oncology (Williston Park)
. 2001 Feb;
14(11A):135-50.
PMID: 11195407
The overall approach to pain management encompassed in these guidelines is comprehensive. It is based on objective pain assessments, utilizes both pharmacologic and nonpharmacologic interventions, and requires continual reevaluation of...
7.
Mystakidou K, Mendoza T, Tsilika E, Befon S, Parpa E, Bellos G, et al.
Oncology
. 2001 Jan;
60(1):35-42.
PMID: 11150906
Objective: The Brief Pain Inventory (BPI) is a pain assessment tool. It has been translated into and validated in several languages. The purpose of this study was the translation into...
8.
9.
Brady A, Cleeland C, Goldstein G, Lefkowitz M, Martens G, Miller S, et al.
Med Interface
. 1996 Dec;
Suppl:10-32.
PMID: 10164785
One of the most important concerns of patients with cancer, particularly those with metastatic disease, is "Will I be in constant pain?" This is a similar concern voiced by patients...
10.
Zhang H, Gu W, Joranson D, Cleeland C
J Pain Symptom Manage
. 1996 Aug;
12(2):124-6.
PMID: 8754998
No abstract available.